FDA.reportPublic FDA data

teplizumab-mzwv 2 MG in 2 ML Injection

RxCUI
2621885
RxNorm name
teplizumab-mzwv 2 MG in 2 ML Injection
Display name
teplizumab-mzwv 2 MG in 2 ML Injection
Full name
teplizumab-mzwv 2 MG in 2 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761183Tzieldteplizumab-mzwv351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e8a39a5f-139c-4510-9777-71cbb00138fateplizumab-mzwv 2 MG in 2 ML InjectionPSN6These highlights do not include all the information needed to use TZIELD safely and effectively. See full prescribing information for TZIELD. TZIELD ® (teplizumab-mzwv) injection, for intravenous use Initial U.S. Approval: 202220260421
e8a39a5f-139c-4510-9777-71cbb00138fa2 ML teplizumab-mzwv 1 MG/ML InjectionSCD6These highlights do not include all the information needed to use TZIELD safely and effectively. See full prescribing information for TZIELD. TZIELD ® (teplizumab-mzwv) injection, for intravenous use Initial U.S. Approval: 202220260421
e8a39a5f-139c-4510-9777-71cbb00138fateplizumab-mzwv 2 MG per 2 ML InjectionSY6These highlights do not include all the information needed to use TZIELD safely and effectively. See full prescribing information for TZIELD. TZIELD ® (teplizumab-mzwv) injection, for intravenous use Initial U.S. Approval: 202220260421